← back to search

Jussi Pihlajamäki

University of Eastern Finland · FI
Area of research
Epidemiology · Physiology
Research interest
Research interests include Liver Disease Diagnosis and Treatment, Adipose Tissue and Metabolism, Diabetes, Cardiovascular Risks, and Lipoproteins, and Adipokines, Inflammation, and Metabolic Diseases.
h-index
73
citations
21,429
works
375
NIH funding
primary concept
Medicine
email

Recent publications

Adipose single cell epigenome and transcriptome localize genetic risk for cardiometabolic disease and accelerated aging.
2026cited by 0position: contributordoi
Metabolic Dysfunction-associated Steatotic Liver Disease Alters Fatty Acid Profiles in the Liver and Adipose Tissue.
2025cited by 3position: contributordoi
Unraveling the Factors Associated With Digital Health Intervention Uptake: Cross-Sectional Study.
2025cited by 0position: contributordoi
Increased secretion of adipocyte-derived extracellular vesicles is associated with adipose tissue inflammation and the mobilization of excess lipid in human obesity
Journal of Translational Medicine 2024cited by 34position: middledoi
Increased secretion of adipocyte-derived extracellular vesicles is associated with adipose tissue inflammation and the mobilization of excess lipid in human obesity.
2024cited by 29position: contributordoi
m6A mRNA methylation in brown fat regulates systemic insulin sensitivity via an inter-organ prostaglandin signaling axis independent of UCP1
Cell Metabolism 2024cited by 23position: middledoi
Single nucleus RNA-sequencing integrated into risk variant colocalization discovers 17 cell-type-specific abdominal obesity genes for metabolic dysfunction-associated steatotic liver disease
eBioMedicine 2024cited by 21position: contributordoi
Single nucleus RNA-sequencing integrated into risk variant colocalization discovers 17 cell-type-specific abdominal obesity genes for metabolic dysfunction-associated steatotic liver disease
EBioMedicine 2024cited by 19position: middledoi
IL32 downregulation lowers triglycerides and type I collagen in di-lineage human primary liver organoids
Cell Reports Medicine 2024cited by 13position: middledoi
Author Correction: Interaction between estrogen receptor-α and PNPLA3 p.I148M variant drives fatty liver disease susceptibility in women
Nature Medicine 2024cited by 3position: middledoi
Integration of single cell omics with biobank data discovers <i>trans</i> effects of <i>SREBF1</i> abdominal obesity risk variants on adipocyte expression of more than 100 genes
2024cited by 2position: contributordoi
Modification in mitochondrial function is associated with the FADS1 variant and its interaction with alpha-linolenic acid-enriched diet-An exploratory study.
2024cited by 1position: contributordoi
Protein Phosphatase 1 Regulatory Subunit 3 Beta rs4240624 Genotype Is Associated With Gallstones and With Significant Changes in Bile Lipidome
Gastro Hep Advances 2024cited by 1position: middledoi
Unraveling the Factors Associated With Digital Health Intervention Uptake: Cross-Sectional Study (Preprint)
2024cited by 0position: contributordoi
Interaction between estrogen receptor-α and PNPLA3 p.I148M variant drives fatty liver disease susceptibility in women
Nature Medicine 2023cited by 123position: middledoi
Cross-tissue omics analysis discovers ten adipose genes encoding secreted proteins in obesity-related non-alcoholic fatty liver disease
EBioMedicine 2023cited by 65position: middledoi
Real-world effectiveness of digital and group-based lifestyle interventions as compared with usual care to reduce type 2 diabetes risk - A stop diabetes pragmatic randomised trial.
2023cited by 19position: contributordoi
Changes in liver metabolic pathways demonstrate efficacy of the combined dietary and microbial therapeutic intervention in MASLD mouse model
Molecular Metabolism 2023cited by 15position: middledoi
Programmed cell death 1 genetic variant and liver damage in nonalcoholic fatty liver disease
Liver International 2023cited by 6position: middledoi
Programmed cell death 1 genetic variant and liver damage in nonalcoholic fatty liver disease.
2023cited by 4position: contributordoi
Immigrants' perspectives on healthy life and healthy lifestyle counseling: a focus group study.
2023cited by 2position: contributordoi
Sex Differences in the Indole-3-propionic Acid Responses to Laparoscopic Roux-en-Y gastric Bypass
2023cited by 0position: contributordoi
Distinct contributions of metabolic dysfunction and genetic risk factors in the pathogenesis of non-alcoholic fatty liver disease.
2022cited by 128position: contributordoi
Rare ATG7 genetic variants predispose patients to severe fatty liver disease
Journal of Hepatology 2022cited by 90position: middledoi
Rare ATG7 genetic variants predispose patients to severe fatty liver disease.
2022cited by 73position: contributordoi
Indolepropionic Acid, a Gut Bacteria-Produced Tryptophan Metabolite and the Risk of Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease.
2022cited by 44position: contributordoi
Identification of 90 NAFLD GWAS loci and establishment of NAFLD PRS and causal role of NAFLD in coronary artery disease.
2022cited by 38position: contributordoi
Integration of questionnaire-based risk factors improves polygenic risk scores for human coronary heart disease and type 2 diabetes.
2022cited by 38position: contributordoi
PSD3 downregulation confers protection against fatty liver disease.
2022cited by 32position: contributordoi
Digitally Supported Lifestyle Intervention to Prevent Type 2 Diabetes Through Healthy Habits: Secondary Analysis of Long-Term User Engagement Trajectories in a Randomized Controlled Trial.
2022cited by 15position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

· 35 papers (2019–2026)Marjukka Kolehmainen · University of Eastern Finland17 papers (2019–2023)Pilvikki Absetz · Tampere University15 papers (2019–2023)Jaana Lindström · Finland University13 papers (2017–2025)Stefano Romeo · Southern Medical University12 papers (2019–2023)Rosellina Margherita Mancina · Università Campus Bio-Medico11 papers (2019–2024)Anna Ludovica Fracanzani · University of Milan11 papers (2019–2023)Ville Männistö · University of Eastern Finland11 papers (2020–2024)Luca V. C. Valenti · Memorial Hospital10 papers (2019–2023) · 10 papers (2020–2025)Päivi Pajukanta · University of California, Los Angeles9 papers (2012–2024)Dorota Kamińska · University of California, Los Angeles9 papers (2021–2024)Tanja Tilles-Tirkkonen · University of Eastern Finland9 papers (2019–2022)Timo A. Lakka · Foundation for Research in Health Systems8 papers (2020–2023)Ursula Schwab · Partners In Care8 papers (2019–2025)Leila J. Karhunen · University of Eastern Finland7 papers (2020–2023)Kati Hanhineva · University of Turku7 papers (2019–2022)Ville Männistö · University of Milan7 papers (2019–2025)Paola Dongiovanni · Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico7 papers (2019–2023)Zong Miao · Second Military Medical University6 papers (2021–2024)